{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T06:37:31Z","timestamp":1787639851040,"version":"build-2736575974"},"reference-count":36,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","semarthritisrheumatism.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.semarthrit.2016.08.011","type":"journal-article","created":{"date-parts":[[2016,8,29]],"date-time":"2016-08-29T16:31:19Z","timestamp":1472488279000},"page":"423-429","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":59,"title":["Moderating effects of immunosuppressive medications and risk factors for post-operative joint infection following total joint arthroplasty in patients with rheumatoid arthritis or osteoarthritis"],"prefix":"10.1016","volume":"46","author":[{"given":"Elizabeth","family":"Salt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda T.","family":"Wiggins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary Kay","family":"Rayens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brent J.","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Mannino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Hoellein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan P.","family":"Donegan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie J.","family":"Crofford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semarthrit.2016.08.011_bib1","unstructured":"Center for Disease Control. Inpatient surgery. \u3008http:\/\/www.cdc.gov\/nchs\/fastats\/inpatient-surgery.htm\u3009 [accessed 04.08.15]."},{"key":"10.1016\/j.semarthrit.2016.08.011_bib2","first-page":"166","article-title":"Nationwide trends in total shoulder arthroplasty and hemiarthroplasty for osteoarthritis","volume":"43","author":"Trofa","year":"2014","journal-title":"Am J of Orthop"},{"key":"10.1016\/j.semarthrit.2016.08.011_bib3","unstructured":"U.S. Department of Health and Human Services. Health, United States. \u3008http:\/\/www.cdc.gov\/nchs\/fastats\/inpatient-surgery.htm; 2014\u3009 [accessed 04.08.15]."},{"key":"10.1016\/j.semarthrit.2016.08.011_bib4","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1002\/acr.22497","article-title":"Rheumatoid arthritis is associated with higher 90-day hospital readmission rates compared to osteoarthritis after hip or knee arthroplasty: a cohort study","volume":"67","author":"Singh","year":"2015","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.semarthrit.2016.08.011_bib5","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1007\/s11999-008-0209-4","article-title":"Periprosthetic joint infection: the incidence, timing, and predisposing factors","volume":"466","author":"Pulido","year":"2008","journal-title":"Clin Orthop Relat Res"},{"key":"10.1016\/j.semarthrit.2016.08.011_bib6","doi-asserted-by":"crossref","first-page":"3102","DOI":"10.1007\/s11999-013-2949-z","article-title":"Has the rate of in-hospital infections after total joint arthroplasty decreased?","volume":"471","author":"Rasouli","year":"2013","journal-title":"Clin Orthop Relat Res"},{"key":"10.1016\/j.semarthrit.2016.08.011_bib7","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1007\/s00264-010-1134-1","article-title":"Failure following revision total knee arthroplasty: infection is the major cause","volume":"35","author":"Mortazavi","year":"2011","journal-title":"Int Orthop"},{"key":"10.1016\/j.semarthrit.2016.08.011_bib8","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1016\/j.arth.2013.06.032","article-title":"Incidence of and risk factors for 30-day readmission following elective primary total joint arthroplasty: analysis from the ACS-NSQIP","volume":"28","author":"Pugely","year":"2013","journal-title":"J Arthroplast"},{"key":"10.1016\/j.semarthrit.2016.08.011_bib9","doi-asserted-by":"crossref","first-page":"775","DOI":"10.2106\/JBJS.L.00211","article-title":"Risk factors associated with deep surgical site infection after primary total knee arthroplasty","volume":"95","author":"Namba","year":"2013","journal-title":"J Bone Joint Surg Am"},{"key":"10.1016\/j.semarthrit.2016.08.011_bib10","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1302\/0301-620X.94B10.29184","article-title":"Risk factors associated with surgical site infection in 30,941 primary total hip replacements","volume":"94-B","author":"Namba","year":"2012","journal-title":"J Bone Joint Surg Am"},{"key":"10.1016\/j.semarthrit.2016.08.011_bib11","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.1007\/s11999-014-3696-5","article-title":"Patient and procedure-specific risk factors for deep infection after primary shoulder arthroplasty","volume":"472","author":"Richards","year":"2014","journal-title":"Clin Orthop Relat Res"},{"key":"10.1016\/j.semarthrit.2016.08.011_bib12","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1007\/s11999-008-0551-6","article-title":"Obese diabetic patients are at substantial risk for deep infection after primary TKA","volume":"467","author":"Dowsey","year":"2009","journal-title":"Clin Orthop Relat Res"},{"key":"10.1016\/j.semarthrit.2016.08.011_bib13","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1177\/193229681100500231","article-title":"Perioperative hyperglycemia and postoperative infection after lower limb arthroplasty","volume":"5","author":"Mraovic","year":"2011","journal-title":"J Diabetes Sci Technol"},{"key":"10.1016\/j.semarthrit.2016.08.011_bib14","doi-asserted-by":"crossref","first-page":"e101","DOI":"10.2106\/JBJS.J.01935","article-title":"Obesity, diabetes, and perioperative joint infection: a single-center analysis of 7181 primary hip and knee replacement for osteoarthritis","volume":"94","author":"J\u00e4msen","year":"2012","journal-title":"J Bone Joint Surg Am"},{"key":"10.1016\/j.semarthrit.2016.08.011_bib15","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.jhin.2011.06.001","article-title":"Risk factors for prosthetic hip and knee infections according to arthroplasty site","volume":"79","author":"Peel","year":"2011","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.semarthrit.2016.08.011_bib16","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1016\/j.jse.2012.01.006","article-title":"Periprosthetic infections after total shoulder arthroplasty: a 33-year perspective","volume":"21","author":"Singh","year":"2013","journal-title":"J Shoulder Elbow Surg"},{"key":"10.1016\/j.semarthrit.2016.08.011_bib17","doi-asserted-by":"crossref","first-page":"e158","DOI":"10.2106\/JBJS.M.01363","article-title":"Risk factors for surgical site infection following total joint arthroplasty","volume":"96","author":"Rasouli","year":"2014","journal-title":"J Bone Joint Surg"},{"key":"10.1016\/j.semarthrit.2016.08.011_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2011\/146398","article-title":"Smoking is a risk factor for short-term outcomes following primary total hip and knee replacement in veterans","volume":"63","author":"Singh","year":"2011","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.semarthrit.2016.08.011_bib19","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1002\/art.24060","article-title":"Incidence and risk factors of prosthetic joint infection after total hip or knee replacement in patients with rheumatoid arthritis","volume":"59","author":"Bongartz","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2016.08.011_bib20","doi-asserted-by":"crossref","first-page":"469","DOI":"10.3109\/s10165-011-0423-x","article-title":"Prosthetic joint infection after total hip or knee arthroplasty in rheumatoid arthritis patients treated with nonbiologic and biologic disease-modifying antirheumatic drugs","volume":"21","author":"Momohara","year":"2011","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.semarthrit.2016.08.011_bib21","doi-asserted-by":"crossref","first-page":"R145","DOI":"10.1186\/ar3087","article-title":"Risk factors for total joint arthroplasty infection in patients receiving tumor necrosis factor-\u03b1 blockers: a case\u2013control study","volume":"12","author":"Gilson","year":"2010","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.semarthrit.2016.08.011_bib22","first-page":"430","article-title":"Complication rates of 127 surgical procedures performed in rheumatic patients receiving tumor necrosis factor alpha blockers","volume":"25","author":"Ruyssen-Witrand","year":"2007","journal-title":"Clin Exp Rheumol"},{"key":"10.1016\/j.semarthrit.2016.08.011_bib23","first-page":"689","article-title":"Risk factors for surgical site infections and other complications in elective surgery in patients with rheumatoid arthritis with special attention for anti-tumor necrosis factor: a large retrospective study","volume":"34","author":"Broeder","year":"2007","journal-title":"J Rheumatol."},{"key":"10.1016\/j.semarthrit.2016.08.011_bib24","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1136\/ard.2005.037762","article-title":"Surgery in patients receiving anti-tumor necrosis factor \u03b1 treatment in rheumatoid arthritis: an observational study on 50 surgical procedures","volume":"64","author":"Wendling","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2016.08.011_bib25","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1136\/ard.2004.028365","article-title":"Tumor necrosis factor \u03b1 antagonists and early postoperative complications in patients with inflammatory joint disease undergoing elective orthopaedic surgery","volume":"64","author":"Talwalkar","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2016.08.011_bib26","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1093\/rheumatology\/kep376","article-title":"Complications and features after joint surgery in rheumatoid arthritis patients treated with tumour necrosis factor-\u03b1 blocker: perioperative interruption of tumour necrosis factor-\u03b1 blockers decreases complications?","volume":"49","author":"Kawakami","year":"2010","journal-title":"Rheumatology"},{"key":"10.1016\/j.semarthrit.2016.08.011_bib27","article-title":"Predicting infections after total joint arthroplasty using a prescription based comorbidity measure","author":"Inacio","year":"2015","journal-title":"J Arthroplasty"},{"key":"10.1016\/j.semarthrit.2016.08.011_bib28","doi-asserted-by":"crossref","first-page":"3839","DOI":"10.1002\/art.37690","article-title":"A systematic review and meta-analysis comparing complications following total joint arthroplasty for rheumatoid arthritis versus for osteoarthritis","volume":"64","author":"Ravi","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2016.08.011_bib29","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1002\/acr.21641","article-title":"Update of the 2008 ACR recommendations for the use of disease-modifying anti-rheumatic drugs and biologic agents in the treatment of rheumatoid arthritis","volume":"64","author":"Singh","year":"2012","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.semarthrit.2016.08.011_bib30","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/acr.20036","volume":"62","author":"Schrama","year":"2015","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.semarthrit.2016.08.011_bib31","doi-asserted-by":"crossref","first-page":"3446","DOI":"10.1007\/s11999-015-4278-x","article-title":"Are there modifiable risk factors for hospital readmission after total hip arthroplasty in a US healthcare system?","volume":"473","author":"Paxton","year":"2015","journal-title":"Clin Orthop Relat Res"},{"key":"10.1016\/j.semarthrit.2016.08.011_bib32","first-page":"480","article-title":"Factors predicting complication rates following total knee replacement","volume":"88A","author":"SooHoo","year":"2006","journal-title":"J Bone Joint Surg"},{"key":"10.1016\/j.semarthrit.2016.08.011_bib33","article-title":"Predictors of hospital readmission following revision total knee arthroplasty","author":"Belmont","year":"2015","journal-title":"Knee Surg Sports Traumatol Arthrosc"},{"key":"10.1016\/j.semarthrit.2016.08.011_bib34","unstructured":"Centers for Disease Control. List of medications contraindicating receipt of smallpox vaccine. \u3008https:\/\/www.google.com\/?gws_rd=ssl#q=List+of+Medications++Contraindicating+Receipt+of+Smallpox+Vaccine+and+pdf\u3009 [accessed 04.08.15]."},{"key":"10.1016\/j.semarthrit.2016.08.011_bib35","first-page":"S1297","article-title":"Crystal-induced arthritis after arthroplasty: 7 cases","volume":"22","author":"Yahia","year":"2016","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.semarthrit.2016.08.011_bib36","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1097\/BCO.0b013e3181d08223","article-title":"Racial variations in the utilization of knee and hip joint replacement: an introduction and review of the most recent literature","volume":"21","author":"Ibrahim","year":"2010","journal-title":"Curr Orthop Pract"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017216302074?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017216302074?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,8]],"date-time":"2018-09-08T19:20:18Z","timestamp":1536434418000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017216302074"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["S0049017216302074"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2016.08.011","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Moderating effects of immunosuppressive medications and risk factors for post-operative joint infection following total joint arthroplasty in patients with rheumatoid arthritis or osteoarthritis","name":"articletitle","label":"Article Title"},{"value":"Seminars in Arthritis and Rheumatism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semarthrit.2016.08.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}